NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

Zevra Therapeutics NASDAQ: ZVRA reported second-quarter 2026 net revenue of $39.7 million, up 53% fr

Zevra Therapeutics, Inc. (ZVRA) Q2 2026 Earnings Call Transcript

Zevra Therapeutics (ZVRA) came out with quarterly earnings of $0.25 per share, beating the Zacks Con

$39.7 million net revenue for Q2 2026, driven by $30.2 million in revenue from MIPLYFFA 53% increase

NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the C

Zevra investors who relied on public statements about arimoclomol's approval status faced losses aft

Longitudinal study includes first published real-world data on arimoclomol in adults with NPC and pr

Zevra Therapeutics (NASDAQ: ZVRA - Get Free Report) and Cocrystal Pharma (NASDAQ: COCP - Get Free Re

Zevra Therapeutics investors saw shares fall after European regulators issued a negative opinion on

NEW YORK, July 30, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

NEW YORK--(BUSINESS WIRE)--On July 24, 2026, Zevra Therapeutics (NASDAQ: ZVRA) shares fell approxima

LOS ANGELES--(BUSINESS WIRE)---- $ZVRA--ZVRA Investors Have Opportunity to Join Zevra Therapeutics,

[url="]Schall, Brown and Schwartz[/url] LLP (“SBS”), a national shareholder rights litigation fi

Zvera investors saw shares fall roughly 24% after European regulators issued a negative CHMP opinion

Wall Street analysts changed outlook on top names. See all rating changes on Benzinga's analyst

Shares of Zevra Therapeutics, Inc. (NASDAQ: ZVRA - Get Free Report) gapped down prior to trading on

Gainers Tenet Healthcare (NYSE:THC) stock increased by 17.3% to $233.54 during Friday's regular

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) shares are trading lower on Friday as the company faces chall

Gainers Advanced Biomed (NASDAQ:ADVB) shares moved upwards by 28.3% to $21.53 during Friday's p

Company plans to request re-examination following negative CHMP opinion for arimoclomol MAA Zevra co

Zevra Therapeutics surged after Miplyffa's patent was listed in the FDA Orange Book, granting exclus

Dow Jones index up 200 points on Tuesday, NIO Inc. gained following better-than-expected financial r

ZVRA up in pre-market trading on better-than-expected Q4 results. Gainers include BRTX, COOT, BIYA,

Retail investors are preparing for another busy week of earnings season with more than 1,600 compani

Shares of PepGen Inc. (NASDAQ: PEPG) rose sharply in pre-market trading after the company announced

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quart

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report q

Companies Reporting Before The Bell • Caledonia Mining (AMEX:CMCL) is expected to report earnings f

The Dow Jones closed lower by more than 250 points on Wednesday. When insiders purchase or sell shar

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announ

Companies Reporting Before The Bell • Cohen & Co (AMEX:COHN) is likely to report earnings for i